OTC Markets OTCQB - Delayed Quote USD

QHSLab, Inc. (USAQ)

Compare
0.1040 -0.0260 (-20.00%)
As of September 24 at 2:44 PM EDT. Market Open.
Loading Chart for USAQ
DELL
  • Previous Close 0.1300
  • Open 0.1010
  • Bid 0.0875 x --
  • Ask 0.1200 x --
  • Day's Range 0.1010 - 0.1040
  • 52 Week Range 0.0160 - 0.3500
  • Volume 12,264
  • Avg. Volume 7,850
  • Market Cap (intraday) 1.091M
  • Beta (5Y Monthly) -0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

www.usaqcorp.com

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: USAQ

View More

Performance Overview: USAQ

Trailing total returns as of 9/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

USAQ
15.56%
S&P 500
20.12%

1-Year Return

USAQ
160.00%
S&P 500
32.63%

3-Year Return

USAQ
87.00%
S&P 500
28.60%

5-Year Return

USAQ
10.64%
S&P 500
93.14%

Compare To: USAQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: USAQ

View More

Valuation Measures

Annual
As of 9/24/2024
  • Market Cap

    1.09M

  • Enterprise Value

    2.66M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.63

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.65

  • Enterprise Value/EBITDA

    24.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.81%

  • Return on Assets (ttm)

    -1.41%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.61M

  • Net Income Avi to Common (ttm)

    -190.5k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    104.2k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    92.44k

Research Analysis: USAQ

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: USAQ

People Also Watch